(Circulation. 1999;99:1972-1977.)
© 1999 American Heart Association, Inc.
Clinical Investigation and Reports |
Determinants and Prognostic Implications of Persistent ST-Segment Elevation After Primary Angioplasty for Acute Myocardial Infarction
Importance of Microvascular Reperfusion Injury on Clinical Outcome
From the Departments of Cardiology (M.J.C., J.B., L.V., C.J.V.) and Intensive Care (P.J., H.D.R.), Antwerp University Hospital, Edegem, Belgium.
Correspondence to Marc Claeys, MD, PhD, Division of Cardiology, Antwerp University Hospital, Wilrijkstraat 10, B-2650 Edegem, Belgium. E-mail mclaeys{at}uia.ua.ac.be
 |
Abstract |
|---|
 Top Abstract IntroductionMethodsResultsDiscussionReferences |
|---|
Background—Despite early recanalization of an occluded infarct artery, reperfusion at the level of the microcirculation may remain impaired owing to a process of microvascular reperfusion injury.
Methods and Results—Microvascular reperfusion injury was studied
in 91 patients with acute myocardial infarction (AMI) by evaluation of
the resolution of ST-segment elevation after successful PTCA.
Impaired microvascular reperfusion, defined as the presence of
persistent (
50% of initial value) ST-segment elevation (ST 50%)
at the end of coronary intervention, was observed in 33
patients (36%) and was independently correlated with low
systolic pressure on admission and high age. Patients 55
years of age with systolic pressures 
120 mm Hg were at
high risk for development of impaired reperfusion compared with
patients not meeting these criteria (72% versus 14%,
P<0.001). Impaired microvascular reperfusion was
associated with a more extensive infarction and worse clinical outcome
at the 1-year follow-up: cardiac death rate, 15% versus 2% (ST 50%
versus ST <50%, P=0.01); nonfatal MI rate, 9% versus
2% (P=0.1); and total major adverse cardiac event
(MACE) rate, 45% versus 15% (P<0.005). ST 50% was
the most important independent determinant of MACE with an adjusted
risk ratio of 3.4.
Conclusions—Impaired microvascular reperfusion, as evidenced by
ST 50% after successful recanalization, occurs
in more than one third of our AMI patients, especially in older
patients with low systolic pressure. Its detrimental
implications on clinical outcome reinforce the need to develop
adjunctive agents that attenuate the process of reperfusion injury.
Key Words: reperfusion • infarction • angioplasty
|
Introduction |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Early recanalization of an occluded coronary artery has become the main goal in the care of acute myocardial infarction (AMI). However, despite successful recanalization by either thrombolytic agents or PTCA, a substantial number of patients still fail to obtain complete and sustained myocardial reperfusion and remain at risk of developing large infarcts.1
There is concern that at the time of reperfusion, further injury occurs to the myocardium. Restoration of blood flow to a previously ischemic zone causes profound physiological and anatomical changes, including neutrophil infiltration, tissue edema, microvascular damage, and subsequent impairment of microcirculatory flow.2 3 4 This so-called low-reflow phenomenon was first described in 1974 by Kloner et al5 in an animal model and observed in humans in 1992 by Ito et al6 using intracoronary contrast echocardiography during primary angioplasty for AMI. Myocardial reperfusion injury has also recently been studied by serial ST-segment analysis during primary angioplasty. Persistent ST-segment elevation shortly after recanalization reflects sustained electrical transmural injury and has been shown to correlate well with impaired myocardial reperfusion at the microcirculatory level and with further extension of myocardial damage after successful primary angioplasty.7 8
The additional prognostic value of microvascular reperfusion injury beyond the well-established prognostic determinants, such as age, extent of myocardial damage, and severity of coronary artery disease, however, is less known. Also, identification of patients at risk for development of impaired microvascular reperfusion has not been determined previously but is important for physicians to tailor more properly adjunctive therapy.
Accordingly, the goal of this study was to identify early determinants of impaired microvascular reperfusion by evaluating the resolution of ST-segment elevation in patients with AMI treated successfully with primary angioplasty and to verify the independent prognostic implications of microvascular reperfusion injury on mortality and morbidity at a 1-year follow-up.
|
Methods |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Patient Population
Between January 1995 and January 1998, a total of 91 patients with AMI, in whom successful primary PTCA for an occluded infarct artery was performed at our institution, were consecutively included in this study. Successful PTCA was defined as adequate restoration of coronary patency (TIMI flow grade
2) and postprocedural
diameter stenosis (%DS) of the infarct artery <50%. All
included patients showed initial ST-segment elevation of >1
mm in 2 contiguous ECG leads and had 12-lead ECGs available
before and at the end of the angioplasty procedure. Patients with left
bundle-branch block or poorly interpretable ST segments were
excluded. All patients received acetylsalicylic acid, and in case of systolic blood pressure >100 mm Hg, intravenous isosorbide dinitrate (0.5 µg · kg-1 · min-1) was started. Cardiogenic shock was defined as persistent low systolic pressure (<90 mm Hg) with clinical signs of left- or right-sided cardiac failure.
Total ischemic time, including the time from beginning of pain to hospital admission (prehospital ischemic time) and the time from admission to first balloon inflation (hospital ischemic time), could be registered in 82 patients. During hospitalization, ß-blocking agents or ACE inhibitors were started according to evidence-based practice guidelines.
Serial measurements of cardiac enzyme release (creatine kinase [CK] with CK-MB isoenzymes) were available in 85 patients, and the maximum level was used as an enzymatic marker of infarct size. Samples were obtained at 4-hour intervals up to 18 hours and later at 8-hour intervals up to 72 hours after intervention.
ECG Analysis
To assess the extent of microvascular reperfusion injury, serial
ST-segment analysis on a 12-lead ECG recording just
before and at the end of the coronary intervention was done by
1 observer blinded to clinical data. The sum of ST-segment elevations
was measured manually with lens-intensified calipers 20 ms after the
end of the QRS complex from leads I, aVL, and V1
through V6 for left anterior descending
coronary artery occlusions and leads II, III, aVF,
V5, V6, and reciprocal
ST-segment depressions in V1 and
V2 for right coronary artery and left
circumflex artery occlusions. Inadequate resolution of ST-segment
elevation after successful recanalization was
expressed as a percentage of the initial ST-segment elevation (%ST).
Persistent ST-segment elevation 50% of the initial value (ST 50%)
was defined as a marker of impaired microvascular reperfusion. On the
other hand, ST-segment elevations <50% indicated good myocardial
reperfusion.
With regard to the reproducibility of ST-segment measurements, we demonstrated in a previous report a close correlation (R2=0.94) between 2 measurements analyzed by 2 independent cardiologists.9
In addition to ST-segment measurements, the 32-point Selvester QRS
score was calculated from the standard 12-lead ECG to assess the amount
of myocardial damage. This QRS score has been validated in AMI patients
and has been shown to correlate well with infarct size.10
The QRS score is scaled according to the size of Q waves and R and S
amplitudes. A QRS score of 8 corresponds to a marked reduction in
ejection fraction (<50%). The QRS score was calculated from baseline
ECG just before primary angioplasty (pre-QRS) and from the ECG
recording at a median of 41 days (6 and 68 days) after
angioplasty (post-QRS). The difference between post- and pre-QRS scores
predominantly reflects the amount of necrotic myocardial tissue related
to the process of reperfusion injury.
The QRS score was manually calculated by a cardiologist without knowledge of reperfusion state or other clinical data. The intraobserver and interobserver variabilities were 0.6±0.7 (absolute mean difference ±SD) and 0.7±0.7, respectively, and were determined by recalculating the QRS score in 40 randomly selected study ECGs.
Angiographic Data
Coronary angiography and coronary angioplasty
were performed with standard catheters by use of nonionic,
low-osmolarity contrast agents after administration of 150 U/kg heparin
IV. In case of suboptimal post-PTCA results, a coronary stent
was implanted. No drugs with potentially rheological capacities (eg,
IIb/IIIa receptor blockers or adenosine) were used in study
patients.
Coronary angiographic data were quantitatively analyzed with a computer-based cardiovascular angiography analysis system (CAAS II, Pie Medical Data). Stenosis severity after PTCA was calculated from the minimal luminal diameter and a computer-estimated reference diameter and expressed as percent DS. Multivessel disease was defined as the presence of a lesion with >50% DS in a non–infarct-related coronary artery.
The TIMI angiographic scale was used to determine the recanalization status of the infarct-related artery and was assessed visually.
Clinical Follow-Up
After hospital discharge, patients were followed up for 1 year,
with data recorded from clinic visits and/or telephone calls to the
referral physician.
Three major adverse cardiac events (MACEs) were identified: cardiac death, including sudden death without evidence of a noncardiac origin; nonfatal MI; and hospitalization because of cardiac failure, life-threatening arrhythmias, or recurrent ischemia caused by angiographically documented progression of coronary artery disease. Myocardial infarction was defined by enzymatic or ECG documentation during hospital admission.
For purposes of analysis, elective rehospitalization for cardiac surgery in patients with severe multivessel disease documented at the time of AMI was not considered a MACE. The date of the first event was used in calculating event-free survival. Only 1 event, the most serious in the above order, was tabulated for each patient.
Statistical Analysis
Continuous variables are presented as median value
with 25th and 75th percentiles unless otherwise stated, and comparisons
between groups were made with the Mann-Whitney U test.
Differences between proportions were assessed by
2 analysis.
To identify the determinants of the extent of microvascular reperfusion injury, the relation between the extent of residual %ST and baseline characteristics was examined by forward stepwise linear regression analysis, with F to enter equal to 4. Clinical baseline variables included age; sex; smoking habits; cardiogenic shock; and history of diabetes, hypertension, hypercholesterolemia (cholesterol >240 mg%), or previous infarction. To define the optimal cutoff value for predictors of impaired microvascular reperfusion, receiver-operator characteristic curve analysis was applied.
Comparison of pre-QRS and post-QRS scores in patients with and without impaired microvascular reperfusion was done by 2-way repeated-measures ANOVA with a post hoc Student-Newman-Keuls test to evaluate differences.
To analyze the impact of microvascular reperfusion injury on
clinical outcome, cumulative event-free survival estimates were plotted
according to the presence or absence of persistent ST-segment elevation
(50 ST% versus <50%) by use of the Kaplan-Meier technique.
Differences between survival curves were tested with the log-rank test.
The Cox proportional-hazards model was applied to verify the
independent prognostic implication of impaired microvascular
reperfusion on clinical outcome. A probability value of
P<0.05 was considered statistically significant.
|
Results |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Patient Population
A total of 91 patients (62 men; age, 64 years [54 and 70]) were admitted in the hospital with AMI. Prehospital ischemic time and in-hospital ischemic time were 174 minutes (70 and 218 minutes) and 57 minutes (45 and 71 minutes), respectively, resulting in a median total ischemic time of 220 minutes (142 and 298 minutes). Successful restoration of the infarct artery patency was achieved in all study patients (TIMI grade 3 flow in 75 patients and TIMI grade 2 flow in 16 patients) with a median postinterventional DS of 22% (15 and 35). A coronary stent was implanted in 38 patients.
Cardiogenic shock was present in 12 patients (13%). A total of 42 patients showed multivessel disease on the initial angiogram, and 11 patients had a history of previous infarction.
Microvascular Reperfusion Injury and Infarct Size
The extent of microvascular reperfusion injury was variable,
as evidenced by the wide range of residual %ST after primary
angioplasty going of 0% to 210% with a median value of 38% (25% and
66%). Impaired microvascular reperfusion, evidenced by ST 50%, was
observed in 33 patients (36%).
ECG evaluation of infarct size revealed more progression of myocardial
necrosis in patients with impaired microvascular reperfusion: QRS score
worsened from a medium value of 3.2 before intervention to 3.8 at
follow-up in patients with ST <50% and from 3.2 to 6.0 in patients
with ST 50% (P<0.01, ST <50% versus 50%). The
median difference between post- and pre-QRS scores, reflecting
predominantly the amount of myocardial necrosis related to reperfusion
injury, was 3±2.3 (±SD) in patients with impaired reperfusion and
0.7±2.2 in patients with good myocardial reperfusion
(P<0.001). A marked left ventricular
dysfunction (QRS score at follow up 8) was present in 7 patients
(22%) with severe microvascular reperfusion injury and in 8 patients
(14%) without severe injury (P=0.3).
Analysis of cardiac enzyme release revealed more extensive
myocardial injury in patients with impaired microvascular reperfusion.
Maximum CK-MB level was 284±248 U/L in patients with ST 50% versus
188±154 U/L in patients with ST <50% (P<0.05).
The time from first balloon inflation to peak CK-MB level did not
differ between both subgroups (530±246 versus 578±311 minutes,
P=0.5).
Determinants of Microvascular Reperfusion Injury
From a variety of baseline characteristics, univariate
analysis identified systolic blood pressure on
admission (r=0.39, P=0.0001), age
(r=0.26, P=0.01), the presence of cardiogenic
shock (r=0.27, P=0.01), and the presence of
multivessel disease (r=0.21, P=0.04) as
significant factors relating to the extent of residual ST-segment
elevation after recanalization. Stepwise regression
analysis selected systolic blood pressure on admission
(F to remove, 17) and age (F to remove, 9) as the only independent
determinants of %ST. Patients with impaired microvascular reperfusion
had lower systolic pressure on admission (100 versus 140
mm Hg) and were older (68 versus 62 years) than patients with good
myocardial reperfusion. Systolic blood pressure in the
catheterization laboratory just before intervention was
not significantly related to the extent of residual ST-segment
elevation (r=0.15, P=0.2).
Patients with persistent ST-segment elevation showed more TIMI grade 2
flow and had longer total ischemic time compared with patients
with ST <50%, but this did not reach statistical significance (see
Table 1
).
|
With receiver-operator characteristic curve analysis, a value
of 120 mm Hg for systolic blood pressure on admission and
55 years for age were defined as the optimal cutoff criteria to predict
the presence of severe microvascular reperfusion injury. A combination
of a systolic pressure on admission 120 mm Hg and age
55 years identified a subgroup of patients at high risk to develop
persistent (50%) ST-segment elevation after successful PTCA compared
with patients meeting only 1 of these criteria (72% versus 14%,
P<0.001). Patients <55 years of age with a
systolic blood pressure on admission of >120 mm Hg
showed the lowest occurrence rate of impaired microvascular reperfusion
(7%), whereas patients meeting only 1 of these criteria constituted a
subgroup at intermediate risk (12% and 17%) (see Figure 1).
|
Microvascular Reperfusion Injury and Clinical Outcome
During clinical follow-up, a total of 24 patients suffered from an
MACE. Three patient deaths were of noncardiac origin.
There were 6 cardiac deaths, including 3 sudden cardiac deaths, 2 deaths after progressive heart failure, and 1 death in the setting of reinfarction. Nonfatal MI occurred in 4 patients, all of them due to reocclusion of the infarct artery. Cardiac death and MI always occurred within 1 month of the index infarction. In addition, a total of 14 patients had to be hospitalized because of recurrent ischemia (n=10), cardiac failure (n= 2), or severe arrhythmia (n=2). Recurrent ischemia was related to restenosis of the infarct artery in 8 patients. Revascularization was performed in 11 patients by either PTCA (n=6) or CABG (n=5).
Table 2 summarizes the different MACEs
stratified according to the presence or absence of severe microvascular
reperfusion injury. Cardiac death and reinfarction were significantly
more present in patients with impaired microvascular reperfusion
(P<0.01 for combined end point). Furthermore, cardiac
failure and severe arrhythmias tended to occur more frequently
in patients with persistent ST-segment elevation. Clinical
restenosis rate, excluding early reocclusion, seemed not to be
influenced by the presence of microvascular reperfusion injury: 8% (2
of 25) in patients with ST 50% versus 11% (6 of 56) in patients
with ST <50%.
|
In Figure 2, cumulative event-free
survival estimates for MACE were plotted according to the presence or
absence of severe microvascular reperfusion injury. Patients with ST
50% had worse clinical outcome than patients with ST <50% (MACE,
45% versus 15%; P<0.01). Further analysis also
revealed that in patients with TIMI grade 3 flow, the presence of
persistent ST-segment elevation could discriminate between patients
with poor and good clinical outcome: MACE rate, 37% in the 24 patients
with ST 50% versus 14% in the 51 patients with ST <50%
(P=0.01).
|
) versus patients with good myocardial reperfusion
(ST<50%, 
). Log-rank test revealed significant difference
(P<0.01) between MACE rate of both subgroups.
To verify the independent prognostic implication of microvascular
reperfusion injury on clinical outcome, multivariate
analysis was performed, including those variables with
P to enter <0.2 on univariate analysis
(Table 3). The Cox proportional-hazards
model selected the presence of impaired microvascular reperfusion as
the most important independent determinant of MACE with an adjusted
risk ratio of 3.4 (95% CI, 1.5 to 7.9). Age, the presence of
cardiogenic shock, the extent of coronary artery disease, TIMI
flow grading, and cholesterol level also tended to be
important factors, but they did not reach significant independence in
multivariate analysis model.
|
|
Discussion |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
This study underlines the importance and clinical relevance of myocardial reperfusion at the level of microcirculation and conveys clinical information on the process of microvascular reperfusion injury.
The inability to adequately perfuse previously ischemic tissue has been attributed to ischemia- and/or reperfusion-induced microvascular damage and is associated with impaired microcirculatory flow with loss of its vasodilating capacity, which may last several weeks after the acute event.11 Previous clinical studies with contrast echocardiography or PET revealed zones of impaired tissue flow in one fourth to one third of patients with reperfused acute myocardial infarction and could demonstrate a good correlation between low myocardial reflow and extension of infarct size.12 13
The occurrence and extent of this microvascular reperfusion injury, however, seem to be variable, as could be derived from the wide range of ST-segment resolution in the present study. Old age and low systolic blood pressure on admission were identified as the most important independent determinants of persistent ST-segment elevation. It is well known that the vasodilating capacity of the microcirculation diminishes with age, most likely because of progressive atherosclerosis and endothelium dysfunction.14 15 We may postulate that ischemia/reperfusion-induced microvascular damage leads to more severe impairment of microcirculatory flow in old patients because of a preexisting endothelium dysfunction.
Low systolic blood pressure on admission was the most
powerful determinant of impaired microvascular reperfusion. A direct
causal relationship between low systolic pressure and impaired
myocardial reperfusion is unlikely because this association disappeared
when blood pressures just before intervention and after administration
of blood pressure–modulating drugs were taken into account. Therefore,
a common underlying pathophysiological mechanism
seems to be more relevant. Inflammatory responses induced by
ischemia/reperfusion are a possible but still-to-be-proved link
between low systolic pressure and microvascular reperfusion
injury because some proinflammatory cytokines (such as tumor
necrosis factor-
) might lower blood pressure through their potent
negative inotropic and vasodilating properties.16 17
Beyond identification of determinants of reperfusion injury, the present study evaluated its prognostic implications. We could demonstrate that the well-known beneficial effect from timely coronary reperfusion on clinical outcome was offset, at least in part, by the presence of severe reperfusion injury. The detrimental effect of severe reperfusion injury was mainly related to reocclusion of the infarct artery, cardiac failure, and severe arrhythmia, including sudden death. Experimental evidence suggests that ischemia/reperfusion-related microvascular injury creates a prothrombotic environment by formation and exposure of more procoagulant factors, partial inhibition of the fibrinolytic system, and fostering of platelet aggregation mainly because of marked depression of nitric oxide levels during reperfusion.18 More extensive microvascular reperfusion injury with subsequently more extensive myocardial tissue necrosis may also constitute a substrate for severe arrhythmias and cardiac failure.
The detrimental and independent clinical implications of microvascular
reperfusion injury reinforce the need to design adjunctive strategies
that attenuate the process of reperfusion injury. Experimental models
have clearly shown that the maximal beneficial effect of
pharmacological intervention can be expected when blood levels are
already elevated when reperfusion occurs and advocate the
administration of these agents before restoration of vessel
patency.19 20 Appropriate selection of patients might
therefore become important. In the present study, we could identify
a subgroup of patients (age 55 years and admission systolic
pressure 120 mm Hg) at high risk for development of impaired
microvascular reperfusion. Whether these patients will confer the most
benefit from adjunctive therapy deserves confirmation in prospectively
designed intervention trials.
The results of this study should be considered in light of the following limitations. First, myocardial infarct size was assessed semiquantitatively by means of a 32-point QRS score, which might be less objective and accurate than a quantitative analysis such as that done by radionuclide studies. However, serial analysis of the QRS score (before intervention and at follow-up) allowed us to study the effect of microvascular reperfusion injury on final infarct size, which other cardiac imaging techniques would not allow.
Second, our findings are derived from a select population of AMI patients with a relatively high prevalence of cardiogenic shock (13%) who were treated successfully with primary PTCA. Therefore, our results cannot be generalized to all patients presenting as emergencies with AMI.
Third, a cutoff value of 50% residual ST-segment elevation was used to stratify patients into impaired versus adequate microvascular reperfusion. In the literature, different values (eg, 50% and 70%) have been applied for evaluation of myocardial reperfusion.7 21 22 The decision to apply the 50% cutoff value in the present study was further guided by its discriminative effect on progression of myocardial necrosis, as was derived from the serial QRS score measurements. Among several cutoff values, the 50% value was associated with the highest differences in extent of infarct necrosis.
In conclusion, impaired microvascular reperfusion, as evidenced by
persistent ST-segment elevation after successful mechanical
recanalization, occurs in more than one third of
our AMI patients, especially in older (55 years) patients with
systolic pressure 120 mm Hg, and is associated with a
more extensive infarction and an unfavorable clinical outcome. It can
be expected that application of new adjunctive strategies that
adequately attenuate the process of microvascular reperfusion injury
will further improve the short- and intermediate-term prognoses of
patients presenting with AMI.
Received September 14, 1998; revision received January 7, 1999; accepted January 15, 1999.
|
References |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
1. Van de Werf F. Thrombolysis for acute myocardial infarction: why is there no extra benefit after hospital discharge? Circulation.. 1995;91:2862–2864.
2.
Kloner R, Rude R, Carlson N, Maroko P, De Boer L,
Braunwald E. Ultrastructural evidence of microvascular damage and
myocardial cell injury after coronary artery occlusion: which
comes first? Circulation.. 1980;62:945–952.
3.
Kloner R, Giacomelli F, Alker K, Hale S, Matthews R,
Bellows B. Influx of neutrophils into the walls of large epicardial
coronary arteries in response to ischemia/reperfusion.
Circulation. 1991;84:1758–1772.
4.
Willerson J, Watson J, Hutton I, Templeton G, Fixler
D. Reduced myocardial reflow and increased coronary vascular
resistance following prolonged myocardial ischemia in the dog.
Circ Res. 1975;36:771–781.
5. Kloner R, Ganote C, Jennings R. The. "no-reflow" phenomenon after temporary coronary occlusion in the dog. J Clin Invest. 1974;54:1496–1508.
6.
Ito H, Tomooka T, Sakai N, Yu H, Higashino Y, Fujii K,
Masuyama T, Kitabatake A, Minamino T. Lack of myocardial perfusion
immediately after successful thrombolysis: a poor
predictor of poor recovery of left ventricular function in
anterior myocardial infarction. Circulation. 1992;85:1699–1705.
7. van't Hof A, Liem A, De Boer M, Zijlstra F. Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction. Lancet. 1997;350:615–619.[Medline] [Order article via Infotrieve]
8.
van't Hof A, Liem A, Suryapranata H, Hoorntje J, de
Boer M, Zijlstra F. Angiographic assessment of myocardial reperfusion
in patients treated with primary angioplasty for acute myocardial
infarction: myocardial blush grade. Circulation. 1998;97:2302–2306.
9.
Claeys M, Vrints C, Bosmans J, Conraads V, Snoeck
J. Aminophylline inhibits adaptation to ischaemia during
angioplasty: role of adenosine in ischaemic preconditioning.
Eur Heart J. 1996;17:539–544.
10. Juergens C, Fernandes C, Hasche E, Meikle S, Bautovich G, Currie C, Freedman S, Jeremey R. Electrocardiographic measurement of infarct size after thrombolytic therapy. J Am Coll Cardiol. 1996;27:617–624.[Abstract]
11. Claeys M, Vrints C, Bosmans J, Krug B, Blockx P, Snoeck J. Coronary flow reserve during coronary angioplasty in patients with a recent myocardial infarction: relationship to stenosis and myocardial viability. J Am Coll Cardiol. 1996;28:1712–1719.[Abstract]
12.
Ito H, Maruyama A, Iwakura K, Takiuchi S, Masuyama T,
Hori M, Higashino Y, Fujii K, Minamino T. Clinical implications of the
"no reflow" phenomenon. Circulation. 1996;93:223–228.
13.
Maes A, Van de Werf F, Nuyts J, Bormans G, Desmet W,
Mortelmans L. Impaired myocardial tissue perfusion early after
successful thrombolysis: impact on myocardial flow,
metabolism, and function at late follow-up.
Circulation. 1995;92:2072–2078.
14. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801–809.[Medline] [Order article via Infotrieve]
15.
Zeiher A, Drexler H, Wollschläger H, Just H.
Endothelial dysfunction of the coronary
microvasculature is associated with impaired coronary blood
flow regulation in patients with early atherosclerosis.
Circulation. 1991;84:1984–1992.
16.
Katz S, Rao R, Berman J, Schwarz M, Demopoulos L,
LeJemtel T. Pathophysiological correlates of
increased serum tumor necrosis factor in patients with congestive heart
failure: relation to nitric oxide-dependent vasodilation in the forearm
circulation. Circulation. 1994;90:12–16.
17.
Neumann F, Ott I, Gawaz M, Richardt G, Holzapfel H,
Jochum M, Schömig A. Cardiac release of cytokines and
inflammatory responses in acute myocardial infarction.
Circulation. 1995;92:748–755.
18.
Okada H, Woodcock-Mitchell J, Mitchell J, Sakamoto T,
Marutsuka K, Burton E, Fujii S. Induction of plasminogen
activator inhibitor type 1 and type 1 collagen
expression in rat cardiac microvascular endothelial
cells by interleukin-1 and its dependence on oxygen-centered free
radicals. Circulation. 1998;97:2175–2182.
19.
Silver M, Sutton J, Hook S, Lee P, Malycky J, Phillips
M, Ellis S, Topol E, Nicolini F. Adjunctive selectin blockade
successfully reduces infarct size beyond thrombolysis
in the electrolytic canine coronary artery model.
Circulation. 1995;92:492–499.
20. Gurevitch J, Frolkis I, Yuhas Y, Lifschitz-Mercer B, Berger E, Paz Y, Matsa M, Kramer A, Mohr R. Anti-tumor necrosis factor-alpha improves myocardial recovery after ischemia and reperfusion. J Am Coll Cardiol. 1997;30:1554–1561.[Abstract]
21. Fernandez A, Sequeira R, Chakko S, Correa L, de Marchena E, Chahine R, Franceour D, Myerburg R. ST segment tracking for rapid determination of patency of the infarct-related artery in acute myocardial infarction. J Am Coll Cardiol. 1995;26:675–683.[Abstract]
22. Schröder R, Wegscheider K, Schröder K, Dissmann R, Meyer-Sabellek W. Extent of early ST-segment elevation resolution: a strong predictor of outcome in patients with acute myocardial infarction and a sensitive measure to compare thrombolytic regimens. J Am Coll Cardiol. 1995;26:1657–1664.[Abstract]
This article has been cited by other articles:
 |
|
 |
|
  A. Marzocchi, A. Manari, G. Piovaccari, C. Marrozzini, S. Marra, P. Magnavacchi, P. Sangiorgio, L. Marinucci, N. Taglieri, G. Gordini, et al. Randomized comparison between tirofiban and abciximab to promote complete ST-resolution in primary angioplasty: results of the facilitated angioplasty with tirofiban or abciximab (FATA) in ST-elevation myocardial infarction trial Eur. Heart J., December 2, 2008; 29(24): 2972 - 2980. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. E. Buller, Y. Fu, K. W. Mahaffey, T. G. Todaro, P. Adams, C. M. Westerhout, H. D. White, A. W.J. van 't Hof, F. J. Van de Werf, G. S. Wagner, et al. ST-Segment Recovery and Outcome After Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction: Insights From the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Trial Circulation, September 23, 2008; 118(13): 1335 - 1346. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Ikari, M. Sakurada, K. Kozuma, S. Kawano, T. Katsuki, K. Kimura, T. Suzuki, T. Yamashita, A. Takizawa, K. Misumi, et al. Upfront Thrombus Aspiration in Primary Coronary Intervention for Patients With ST-Segment Elevation Acute Myocardial Infarction: Report of the VAMPIRE (VAcuuM asPIration thrombus REmoval) Trial J. Am. Coll. Cardiol. Intv., August 1, 2008; 1(4): 424 - 431. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Galiuto, B. Garramone, A. Scara, A. G. Rebuzzi, F. Crea, G. La Torre, S. Funaro, M. Madonna, F. Fedele, L. Agati, et al. The extent of microvascular damage during myocardial contrast echocardiography is superior to other known indexes of post-infarct reperfusion in predicting left ventricular remodeling: results of the multicenter AMICI study. J. Am. Coll. Cardiol., February 5, 2008; 51(5): 552 - 559. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L A Pierard ST elevation after myocardial infarction: what does it mean? Heart, November 1, 2007; 93(11): 1329 - 1330. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Galiuto, S. Barchetta, S. Paladini, G. Lanza, A. G Rebuzzi, M. Marzilli, and F. Crea Functional and structural correlates of persistent ST elevation after acute myocardial infarction successfully treated by percutaneous coronary intervention Heart, November 1, 2007; 93(11): 1376 - 1380. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 The APEX AMI Investigators Pexelizumab for Acute ST-Elevation Myocardial Infarction in Patients Undergoing Primary Percutaneous Coronary Intervention: A Randomized Controlled Trial JAMA, January 3, 2007; 297(1): 43 - 51. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Mariani, R. Fetiveau, E. Rossetti, A. Poli, F. Poletti, P. Vandoni, M. D'Urbano, F. Cafiero, G. Mariani, C. Klersy, et al. Significance of total and differential leucocyte count in patients with acute myocardial infarction treated with primary coronary angioplasty Eur. Heart J., November 1, 2006; 27(21): 2511 - 2515. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Silva-Orrego, P. Colombo, R. Bigi, D. Gregori, A. Delgado, P. Salvade, J. Oreglia, P. Orrico, A. de Biase, G. Piccalo, et al. Thrombus Aspiration Before Primary Angioplasty Improves Myocardial Reperfusion in Acute Myocardial Infarction: The DEAR-MI (Dethrombosis to Enhance Acute Reperfusion in Myocardial Infarction) Study J. Am. Coll. Cardiol., October 17, 2006; 48(8): 1552 - 1559. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kaltoft, M. Bottcher, S. S. Nielsen, H.-H. T. Hansen, C. Terkelsen, M. Maeng, J. Kristensen, L. Thuesen, L. R. Krusell, S. D. Kristensen, et al. Routine Thrombectomy in Percutaneous Coronary Intervention for Acute ST-Segment-Elevation Myocardial Infarction: A Randomized, Controlled Trial Circulation, July 4, 2006; 114(1): 40 - 47. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Part 8: Stabilization of the Patient With Acute Coronary Syndromes Circulation, December 13, 2005; 112(24_suppl): IV-89 - IV-110. [Full Text] [PDF]
|
|
|
|
 |
|
 A. K. Bilge, Y. Nisanci, E. Yilmaz, B. Ozben, A. Oncul, F. Mercanoglu, and M. Meric Effects of Percutaneous Coronary Thrombectomywith the X-Sizer Catheter on Epicardial Flow and Microvascular Function in Acute Coronary Syndromes Clinical and Applied Thrombosis/Hemostasis, October 1, 2005; 11(4): 461 - 466. [Abstract] [PDF]
|
|
|
|
|
|
U. Zeymer, R. Zahn, R. Schiele, W. Jansen, E. Girth, A. Gitt, K. Seidl, R. Schroder, S. Schneider, and J. Senges Early eptifibatide improves TIMI 3 patency before primary percutaneous coronary intervention for acute ST elevation myocardial infarction: results of the randomized integrilin in acute myocardial infarction (INTAMI) pilot trial Eur. Heart J., October 1, 2005; 26(19): 1971 - 1977. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Ishii, S. Ichimiya, M. Kanashiro, T. Amano, K. Imai, T. Murohara, and T. Matsubara Impact of a Single Intravenous Administration of Nicorandil Before Reperfusion in Patients With ST-Segment-Elevation Myocardial Infarction Circulation, August 30, 2005; 112(9): 1284 - 1288. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Mizote, Y. Ueda, T. Ohtani, M. Shimizu, Y. Takeda, T. Oka, M. Tsujimoto, A. Hirayama, M. Hori, and K. Kodama Distal Protection Improved Reperfusion and Reduced Left Ventricular Dysfunction in Patients With Acute Myocardial Infarction Who Had Angioscopically Defined Ruptured Plaque Circulation, August 16, 2005; 112(7): 1001 - 1007. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Lefevre, E. Garcia, B. Reimers, I. Lang, C. di Mario, A. Colombo, F.-J. Neumann, M. V. Chavarri, P. Brunel, E. Grube, et al. X-Sizer for Thrombectomy in Acute Myocardial Infarction Improves ST-Segment Resolution: Results of the X-Sizer in AMI for Negligible Embolization and Optimal ST Resolution (X AMINE ST) Trial J. Am. Coll. Cardiol., July 19, 2005; 46(2): 246 - 252. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H S Gurm and E J Topol The ECG in acute coronary syndromes: new tricks from an old dog Heart, July 1, 2005; 91(7): 851 - 853. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Sorajja, B. J. Gersh, C. Costantini, M. G. McLaughlin, P. Zimetbaum, D. A. Cox, E. Garcia, J. E. Tcheng, R. Mehran, A. J. Lansky, et al. Combined prognostic utility of ST-segment recovery and myocardial blush after primary percutaneous coronary intervention in acute myocardial infarction Eur. Heart J., April 1, 2005; 26(7): 667 - 674. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. W. Stone, J. Webb, D. A. Cox, B. R. Brodie, M. Qureshi, A. Kalynych, M. Turco, H. P. Schultheiss, D. Dulas, B. D. Rutherford, et al. Distal Microcirculatory Protection During Percutaneous Coronary Intervention in Acute ST-Segment Elevation Myocardial Infarction: A Randomized Controlled Trial JAMA, March 2, 2005; 293(9): 1063 - 1072. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. G. McLaughlin, G. W. Stone, E. Aymong, G. Gardner, R. Mehran, A. J. Lansky, C. L. Grines, J. E. Tcheng, D. A. Cox, T. Stuckey, et al. Prognostic utility of comparative methods for assessment of ST-segment resolution after primary angioplasty for acute myocardial infarction: The controlled abciximab and device investigation to lower late angioplasty complications (CADILLAC) trial J. Am. Coll. Cardiol., September 15, 2004; 44(6): 1215 - 1223. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Iwakura, H. Ito, S. Kawano, A. Okamura, K. Tanaka, Y. Nishida, Y. Maekawa, and K. Fujii Assessing myocardial perfusion with the transthoracic Doppler technique in patients with reperfused anterior myocardial infarction: comparison with angiographic, enzymatic and electrocardiographic indices Eur. Heart J., September 1, 2004; 25(17): 1526 - 1533. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W J Desmet, L V Mesotten, A F Maes, H P Heidbuchel, L A Mortelmans, and F J Van de Werf Relation between different methods for analysing ST segment deviation and infarct size as assessed by positron emission tomography Heart, August 1, 2004; 90(8): 887 - 892. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. O. Costantini, G. W. Stone, R. Mehran, E. Aymong, C. L. Grines, D. A. Cox, T. Stuckey, M. Turco, B. J. Gersh, J. E. Tcheng, et al. Frequency, correlates, and clinical implications of myocardial perfusion after primary angioplasty and stenting, with and without glycoprotein IIb/IIIa inhibition, in acute myocardial infarction J. Am. Coll. Cardiol., July 21, 2004; 44(2): 305 - 312. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. De Luca, A. W.J van't Hof, M.-J. de Boer, J. P. Ottervanger, J. C.A Hoorntje, A.T.M. Gosselink, J.-H. E Dambrink, F. Zijlstra, and H. Suryapranata Time-to-treatment significantly affects the extent of ST-segment resolution and myocardial blush in patients with acute myocardial infarction treated by primary angioplasty Eur. Heart J., June 2, 2004; 25(12): 1009 - 1013. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Cortadellas, J. Figueras, M. Missorici, E. Domingo, J. Rodes, J. Castell, and J. Soler Soler ST segment elevation at 72 hours in patients with a first anterior myocardial infarction best correlates with pre-discharge and 1-year regional contractility and ventricular dilatation Eur. Heart J., February 1, 2004; 25(3): 224 - 231. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. W. Armstrong and R. C. Welsh Tailoring therapy to best suit ST-segment elevation myocardial infarction: searching for the right fit Can. Med. Assoc. J., October 28, 2003; 169(9): 925 - 927. [Full Text]
|
|
|
|
|
|
M. Napodano, G. Pasquetto, S. Sacca, C. Cernetti, V. Scarabeo, P. Pascotto, and B. Reimers Intracoronary thrombectomy improves myocardial reperfusion in patients undergoing direct angioplasty for acute myocardial infarction J. Am. Coll. Cardiol., October 15, 2003; 42(8): 1395 - 1402. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Limbruno, A. Micheli, M. De Carlo, G. Amoroso, R. Rossini, C. Palagi, V. Di Bello, A. S. Petronio, G. Fontanini, and M. Mariani Mechanical Prevention of Distal Embolization During Primary Angioplasty: Safety, Feasibility, and Impact on Myocardial Reperfusion Circulation, July 15, 2003; 108(2): 171 - 176. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. J. Feldman, P. Coste, A. Furber, P. Dupouy, M. S. Slama, J.-P. Monassier, C. Tron, A. Lafont, M. Faraggi, D. Le Guludec, et al. Incomplete Resolution of ST-Segment Elevation Is a Marker of Transient Microcirculatory Dysfunction After Stenting for Acute Myocardial Infarction Circulation, June 3, 2003; 107(21): 2684 - 2689. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Dibra, J. Mehilli, J. Dirschinger, J.u. Pache, J. Neverve, M. Schwaiger, A. Schomig, and A. Kastrati Thrombolysis in myocardial infarction myocardial perfusion grade in angiography correlates with myocardial salvage in patients with acute myocardial infarction treated with stenting or thrombolysis J. Am. Coll. Cardiol., March 19, 2003; 41(6): 925 - 929. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. K. Haager, P. Christott, N. Heussen, W. Lepper, P. Hanrath, and R. Hoffmann Prediction of clinical outcome after mechanical revascularization in acute myocardial infarction by markers of myocardial reperfusion J. Am. Coll. Cardiol., February 19, 2003; 41(4): 532 - 538. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F Beygui, C Le Feuvre, G Helft, C Maunoury, and J P Metzger Myocardial viability, coronary flow reserve, and in-hospital predictors of late recovery of contractility following successful primary stenting for acute myocardial infarction Heart, February 1, 2003; 89(2): 179 - 183. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.S Petronio, D Rovai, G Musumeci, R Baglini, C Nardi, U Limbruno, C Palagi, D Volterrani, and M Mariani Effects of abciximab on microvascular integrity and left ventricular functional recovery in patients with acute infarction treated by primary coronary angioplasty Eur. Heart J., January 1, 2003; 24(1): 67 - 76. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. P. Faxon, R. J. Gibbons, N. A. F. Chronos, P. A. Gurbel, F. Sheehan, and HALT-MI Investigators The effect of blockade of the CD11/CD18 integrin receptor on infarct size in patients with acute myocardial infarction treated with direct angioplasty: the results of the HALT-MI study J. Am. Coll. Cardiol., October 2, 2002; 40(7): 1199 - 1204. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Beygui, C. Le Feuvre, C. Maunoury, G.e. Helft, and J. P. Metzger Coronary vasodilator reserve: a clue to the explanation of 201Tl redistribution patterns early after successful primary stenting for acute myocardial infarction J. Am. Coll. Cardiol., September 4, 2002; 40(5): 877 - 881. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-K. Wong, J.K. French, M.W. Krucoff, W. Gao, P.E. Aylward, and H.D. White Slowed ST segment recovery despite early infarct artery patency in patients with Q waves at presentation with a first acute myocardial infarction. Implications of initial Q waves on myocyte reperfusion Eur. Heart J., September 2, 2002; 23(18): 1449 - 1455. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Poli, R. Fetiveau, P. Vandoni, G. del Rosso, M. D'Urbano, G. Seveso, F. Cafiero, and S. De Servi Integrated Analysis of Myocardial Blush and ST-Segment Elevation Recovery After Successful Primary Angioplasty: Real-Time Grading of Microvascular Reperfusion and Prediction of Early and Late Recovery of Left Ventricular Function Circulation, July 16, 2002; 106(3): 313 - 318. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. J. Goswami, J. M. Moody Jr, and S. R. Bailey Percutaneous Mechanical Reperfusion During Acute Myocardial Infarction J Intensive Care Med, July 1, 2002; 17(4): 162 - 173. [Abstract] [PDF]
|
|
|
|
|
|
G. Beran, I. Lang, W. Schreiber, S. Denk, T. Stefenelli, B. Syeda, G. Maurer, D. Glogar, and P. Siostrzonek Intracoronary Thrombectomy With the X-Sizer Catheter System Improves Epicardial Flow and Accelerates ST-Segment Resolution in Patients With Acute Coronary Syndrome: A Prospective, Randomized, Controlled Study Circulation, May 21, 2002; 105(20): 2355 - 2360. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. W. Dae, D. W. Gao, D. I. Sessler, K. Chair, and C. A. Stillson Effect of endovascular cooling on myocardial temperature, infarct size, and cardiac output in human-sized pigs Am J Physiol Heart Circ Physiol, May 1, 2002; 282(5): H1584 - H1591. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. H. Rezkalla and R. A. Kloner No-Reflow Phenomenon Circulation, February 5, 2002; 105(5): 656 - 662. [Full Text] [PDF]
|
|
|
|
|
|
B. G. Angeja, M. Gunda, S. A. Murphy, B. E. Sobel, A. C. Rundle, M. Syed, A. Asfour, S. Borzak, S. G. Gourlay, H. V. Barron, et al. TIMI Myocardial Perfusion Grade and ST Segment Resolution: Association With Infarct Size as Assessed by Single Photon Emission Computed Tomography Imaging Circulation, January 22, 2002; 105(3): 282 - 285. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Loubeyre, M.-C. Morice, T. Lefevre, J.-F. Piechaud, Y. Louvard, and P. Dumas A randomized comparison of direct stenting with conventional stent implantation in selected patients with acute myocardial infarction J. Am. Coll. Cardiol., January 2, 2002; 39(1): 15 - 21. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Fu, S. Goodman, W.-C. Chang, F. Van de Werf, C. B. Granger, and P. W. Armstrong Time to Treatment Influences the Impact of ST-Segment Resolution on One-Year Prognosis: Insights From the Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT-2) Trial Circulation, November 27, 2001; 104(22): 2653 - 2659. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. de Lemos and E. Braunwald ST segment resolution as a tool for assessing the efficacy of reperfusion therapy J. Am. Coll. Cardiol., November 1, 2001; 38(5): 1283 - 1294. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Giannitsis, M. Muller-Bardorff, S. Lehrke, U. Wiegand, R. Tolg, B. Weidtmann, F. Hartmann, G. Richardt, and H. A. Katus Admission Troponin T Level Predicts Clinical Outcomes, TIMI Flow, and Myocardial Tissue Perfusion After Primary Percutaneous Intervention for Acute ST-Segment Elevation Myocardial Infarction Circulation, August 7, 2001; 104(6): 630 - 635. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U Zeymer, R Schroder, U Tebbe, G.P Molhoek, K Wegscheider, and K.-L Neuhaus Non-invasive detection of early infarct vessel patency by resolution of ST-segment elevation in patients with thrombolysis for acute myocardial infarction. Results of the angiographic substudy of the Hirudin for Improvement of Thrombolysis (HIT)-4 trial Eur. Heart J., May 1, 2001; 22(9): 769 - 775. [Abstract] [PDF]
|
|
|
|
|
|
M. T. Roe, E. M. Ohman, A. C. P. Maas, R. H. Christenson, K. W. Mahaffey, C. B. Granger, R. A. Harrington, R. M. Califf, and M. W. Krucoff Shifting the open-artery hypothesis downstream: the quest for optimal reperfusion J. Am. Coll. Cardiol., January 1, 2001; 37(1): 9 - 18. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. J. Feldman, D. Himbert, J.-M. Juliard, G. J. Karrillon, H. Benamer, P. Aubry, O. Boudvillain, P. Seknadji, M. Faraggi, and P. G. Steg Reperfusion syndrome: relationship of coronary blood flow reserve to left ventricular function and infarct size J. Am. Coll. Cardiol., April 1, 2000; 35(5): 1162 - 1169. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Cotter, E. Kaluski, A. Blatt, O. Milovanov, Y. Moshkovitz, R. Zaidenstein, A. Salah, D. Alon, Y. Michovitz, M. Metzger, et al. L-NMMA (a Nitric Oxide Synthase Inhibitor) is Effective in the Treatment of Cardiogenic Shock Circulation, March 28, 2000; 101(12): 1358 - 1361. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Persistent ST-Segment Elevation Predicts Risk Journal Watch Cardiology, June 3, 1999; 1999(603): 4 - 4. [Full Text]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||